Glycemic Control and Prostate Cancer Mortality Risk in Veterans with Type 2 Diabetes Mellitus
- PMID: 40693585
- PMCID: PMC12314478
- DOI: 10.1158/2767-9764.CRC-25-0037
Glycemic Control and Prostate Cancer Mortality Risk in Veterans with Type 2 Diabetes Mellitus
Abstract
This retrospective cohort study of veterans diagnosed with diabetes mellitus evaluated the association between time-varying measures of glycemic control and the time to prostate cancer-specific mortality. Competing risk Cox regression models were developed to estimate the association of glycemic control and prostate cancer mortality for the entire sample and stratified by racial and ethnic groups. A total of 763,424 veterans with type 2 diabetes mellitus (T2DM) were included. In the fully adjusted models, moderate glycemic control [hemoglobin A1c (HbA1c) 7%-8%] was associated with a 23% (HR, 0.77; 95% confidence interval, 0.68-0.85) lower risk and poor glycemic control (HbA1c >8%) was associated with a 15% (HR, 0.85; 95% confidence interval, 0.71-0.99) lower risk of prostate cancer mortality compared with good glycemic control (HbA1c <7%), respectively. In the analyses stratified by race and ethnicity, moderate glycemic control was associated with a lower risk of prostate cancer mortality in non-Hispanic White and non-Hispanic Black veterans.
Significance: Unlike many other cancers, there is an inverse association between prostate cancer risk and T2DM diagnosis. In this large, retrospective study of male veterans with T2DM, we observed an inverse association between glycemic control and prostate cancer mortality. Further research is required to verify this relationship in prospective studies and identify the potential mechanisms contributing to these findings.
©2025 The Authors; Published by the American Association for Cancer Research.
Conflict of interest statement
M. Gebregziabher reports grants from VA Health Services and Development during the conduct of the study. No other disclosures were reported.
Figures



Similar articles
-
In Search of the Ideal Resistance Training Program to Improve Glycemic Control and its Indication for Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.Sports Med. 2016 Jan;46(1):67-77. doi: 10.1007/s40279-015-0379-7. Sports Med. 2016. PMID: 26604100
-
The association between resting heart rate and HbA1c-assessed glycemic control in patients with type 2 diabetes in Eastern China.Front Endocrinol (Lausanne). 2025 Jun 16;16:1478575. doi: 10.3389/fendo.2025.1478575. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40589519 Free PMC article.
-
Preoperative Glycemic Control and Acute Endophthalmitis after Cataract Surgery in United States Veterans with Diabetes Mellitus.Ophthalmology. 2025 Aug;132(8):903-910. doi: 10.1016/j.ophtha.2025.03.023. Epub 2025 Mar 22. Ophthalmology. 2025. PMID: 40122400
-
Glycated Hemoglobin A1c Time in Range and Dementia in Older Adults With Diabetes.JAMA Netw Open. 2024 Aug 1;7(8):e2425354. doi: 10.1001/jamanetworkopen.2024.25354. JAMA Netw Open. 2024. PMID: 39093563 Free PMC article.
-
Treatment of periodontal disease for glycaemic control in people with diabetes mellitus.Cochrane Database Syst Rev. 2015 Nov 6;2015(11):CD004714. doi: 10.1002/14651858.CD004714.pub3. Cochrane Database Syst Rev. 2015. Update in: Cochrane Database Syst Rev. 2022 Apr 14;4:CD004714. doi: 10.1002/14651858.CD004714.pub4. PMID: 26545069 Free PMC article. Updated.
References
-
- (CDC) CfDCaP . National diabetes statistics report. 2024[cited 2024 Dec 11]. Available from:https://www.cdc.gov/diabetes/php/data-research/index.html.
-
- (CSPEAR) VCSPEAR . Type 2 diabetes mellitus. 2020.
-
- Safadi H, Balogh Á, Lám J, Nagy A, Belicza É. Associations between diabetes and cancer: a 10-year national population-based retrospective cohort study. Diabetes Res Clin Pract 2024;211:111665. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical